These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 7557344)
21. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae. Loera-Muro A; Angulo C Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259 [TBL] [Abstract][Full Text] [Related]
22. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins. Van Overbeke I; Chiers K; Ducatelle R; Haesebrouck F J Vet Med B Infect Dis Vet Public Health; 2001 Feb; 48(1):15-20. PubMed ID: 11254095 [TBL] [Abstract][Full Text] [Related]
23. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae. Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060 [TBL] [Abstract][Full Text] [Related]
24. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge. Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553 [TBL] [Abstract][Full Text] [Related]
25. Serological response to Actinobacillus pleuropneumoniae serovar 7 infection in a commercial pig herd. Gardner IA; Bossé JT; Sheldrake RF; Rosendal S; Johnson RP Aust Vet J; 1991 Nov; 68(11):349-52. PubMed ID: 1776931 [TBL] [Abstract][Full Text] [Related]
26. In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae. Antenucci F; Fougeroux C; Deeney A; Ørskov C; Rycroft A; Holst PJ; Bojesen AM Vet Res; 2018 Jan; 49(1):4. PubMed ID: 29316978 [TBL] [Abstract][Full Text] [Related]
27. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71. Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812 [TBL] [Abstract][Full Text] [Related]
28. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model. Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821 [TBL] [Abstract][Full Text] [Related]
29. Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae. Appleyard GD; Furesz SE; Wilkie BN Vet Immunol Immunopathol; 2002 Jul; 86(3-4):221-8. PubMed ID: 12007888 [TBL] [Abstract][Full Text] [Related]
30. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs. Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053 [TBL] [Abstract][Full Text] [Related]
31. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA]. Liu J; Chen Y; Hu L; Bei W; Chen H Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341 [TBL] [Abstract][Full Text] [Related]
32. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC]. Xu FZ; Shi AH; Chen XL; Yang B; Wang JL Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275 [TBL] [Abstract][Full Text] [Related]
33. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge. Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888 [TBL] [Abstract][Full Text] [Related]
34. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity. Dubreuil JD; Jacques M; Mittal KR; Gottschalk M Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600 [TBL] [Abstract][Full Text] [Related]
35. Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs. Furesz SE; Mallard BA; Bossé JT; Rosendal S; Wilkie BN; MacInnes JI Infect Immun; 1997 Feb; 65(2):358-65. PubMed ID: 9009283 [TBL] [Abstract][Full Text] [Related]
36. Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia. Sadilkova L; Nepereny J; Vrzal V; Sebo P; Osicka R Vet Res; 2012 Jan; 43(1):2. PubMed ID: 22240397 [TBL] [Abstract][Full Text] [Related]
37. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge. Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218 [TBL] [Abstract][Full Text] [Related]
38. Detection and localization of ApxI, -II and -III genes of Actinobacillus pleuropneumoniae in natural porcine pleuropneumonia in natural porcine pleuropneumonia by in situ hybridization. Choi C; Kwon D; Min K; Chae C Vet Pathol; 2001 Jul; 38(4):390-5. PubMed ID: 11467472 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199 [TBL] [Abstract][Full Text] [Related]
40. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines. Willson PJ; Rossi-Campos A; Potter AA Can J Vet Res; 1995 Oct; 59(4):299-305. PubMed ID: 8548692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]